AssetMark Inc
ADPT icon

AssetMark Inc’s Adaptive Biotechnologies ADPT Stock Holding History

AssetMark Inc’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$316K Buy
10,936
+1,757
+19% +$43.2K ﹤0.01% 1342
2026
Q2 		$197K Buy
9,179
+4,758
+108% +$72.9K ﹤0.01% 1444
2026
Q1 		$61.4K Buy
4,421
+1,401
+46% +$22.3K ﹤0.01% 1686
2025
Q4 		$49K Buy
3,020
+2,708
+868% +$44.2K ﹤0.01% 1729
2025
Q3 		$4.67K Buy
312
+111
+55% +$1.35K ﹤0.01% 2367
2025
Q2 		$2.34K Buy
+201
New +$1.83K ﹤0.01% 2382
2024
Q2 		– Sell
-80
Closed -$257 – 2099
2024
Q1 		$257 Sell
80
-4,861
-98% -$18.8K ﹤0.01% 1774
2023
Q4 		$24.2K Buy
4,941
+1,498
+44% +$6.84K ﹤0.01% 1269
2023
Q3 		$18.8K Sell
3,443
-622
-15% -$4.11K ﹤0.01% 1250
2023
Q2 		$27.3K Buy
4,065
+1,462
+56% +$10.9K ﹤0.01% 1177
2023
Q1 		$23K Buy
2,603
+575
+28% +$5.07K ﹤0.01% 1176
2022
Q4 		$15.5K Buy
2,028
+625
+45% +$4.86K ﹤0.01% 1246
2022
Q3 		$10K Buy
1,403
+331
+31% +$3.12K ﹤0.01% 1222
2022
Q2 		$9K Buy
1,072
+827
+338% +$7.27K ﹤0.01% 1227
2022
Q1 		$3K Buy
+245
New +$3.85K ﹤0.01% 1339
2021
Q2 		– Sell
-43
Closed -$2K – 1310
2021
Q1 		$2K Buy
+43
New +$2.33K ﹤0.01% 1152

Other funds holding ADPT

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

AssetMark Inc's ADPT Position: Q3 2026 in Review

AssetMark Inc increased its Adaptive Biotechnologies (ADPT) stake by 19% in Q3 2026, buying an estimated $43.2K and bringing the position to 10,936 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

AssetMark Inc first reported a position in ADPT in Q1 2021 and has held it in 16 quarters since. 109 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • AssetMark Inc held 10,936 shares of Adaptive Biotechnologies worth $316K as of Q3 2026.
  • AssetMark Inc bought 1,757 Adaptive Biotechnologies shares in Q3 2026, an estimated $43.2K.
  • Adaptive Biotechnologies made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1342 holding.
  • AssetMark Inc first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 16 quarters since.
  • 109 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.